1,4-Bis{2-[(2-hydroxyethyl)amino]ethylamino}-9, 10-anthracenedione, an anthraquinone antitumour agent that does not cause lipid peroxidation in vivo; Comparison with daunorubicin
Authors:
- Laurence H. PattersonLPLaurence H. Patterson
- Bijukumar M. GandechaBGBijukumar M. Gandecha
- Jeffrey R. BrownJBJeffrey R. Brown
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 110 (2) , 399-405
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of cardiotoxicity of two anthracenediones and doxorubicin in ratsToxicology Letters, 1982
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.Journal of Clinical Investigation, 1981
- Antiproliferative Activity of Doxorubicin and Aminoanthraquinone Derivatives on Chinese Hamster Ovary CellsJournal of Pharmaceutical Sciences, 1981
- Daunorubicin-stimulated reactive oxygen metabolism in cardiac sarcosomesBiochemical Pharmacology, 1981
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycinBiochemical and Biophysical Research Communications, 1977
- A fluorometric method for determination of oxidized and reduced glutathione in tissuesAnalytical Biochemistry, 1976
- The Metabolism ofN-Ethyl-N-methylaniline by Rabbit Liver Microsomes: The Measurement of Metabolites by Gas-liquid ChromatographyXenobiotica, 1975
- Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagentAnalytical Biochemistry, 1968